Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous Melanoma.

MLA

Ferreira, Ana Maria Castro, et al. “Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous Melanoma.” International Journal of Molecular Sciences, vol. 25, no. 22, Nov. 2024, p. 12327. EBSCOhost, https://doi.org/10.3390/ijms252212327.

APA

Ferreira, A. M. C., Carron, J., Gomez, G. V. B., Vazquez, V. de L., Serrano, S. V., Lourenço, G. J., & Lima, C. S. P. (2024). Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous Melanoma. International Journal of Molecular Sciences, 25(22), 12327. https://doi.org/10.3390/ijms252212327

Chicago

Ferreira, Ana Maria Castro, Juliana Carron, Gabriela Vilas Bôas Gomez, Vinicius de Lima Vazquez, Sergio Vicente Serrano, Gustavo Jacob Lourenço, and Carmen Silvia Passos Lima. 2024. “Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous Melanoma.” International Journal of Molecular Sciences 25 (22): 12327. doi:10.3390/ijms252212327.